STOCK TITAN

OVATION SCIENCE INC - OVATF STOCK NEWS

Welcome to our dedicated news page for OVATION SCIENCE (Ticker: OVATF), a resource for investors and traders seeking the latest updates and insights on OVATION SCIENCE.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect OVATION SCIENCE's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of OVATION SCIENCE's position in the market.

Rhea-AI Summary

Ovation Science Inc. announced the launch of its topical product line in Nevada with Planet 13 Holdings, Inc., featuring both cannabis and hemp-derived products. The partnership aims to expand brand presence and generate revenue for both companies. Ovation's proprietary skin delivery technology, Invisicare®, enhances product effectiveness, with significant CBD release compared to competitors. Planet 13's topicals include various ratios of CBD and THC for relaxation, relief, and recovery. The companies are optimistic about driving growth and optimizing gross margins through this collaboration.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Ovation Science Inc. signs an exclusive licensing agreement with Ripco Processing Inc. for its cannabis products in Canada. Ripco will handle regulatory, manufacturing, marketing, and distribution activities, with Ovation receiving royalties. The agreement allows Ovation to launch its InVibeMD product line in early Q3 of 2024, expanding its market presence and revenue potential.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
18%
Tags
none
-
Rhea-AI Summary
Ovation Science USA Inc. has signed an exclusive licensing agreement with MidWest Roots, LLC for its topical/transdermal cannabis formulations in Missouri. MidWest will handle regulatory, manufacturing, marketing, sales, and distribution activities, while Ovation will receive royalty income. Missouri is one of the largest cannabis markets, with over 200 dispensaries and $1.3 billion in sales as of August 2023. MidWest, known for its expertise in cannabis and consumer goods, plans to launch Ovation's products in late Q4 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
40.35%
Tags
none
Rhea-AI Summary
Ovation Science signs license agreement with Planet 13 for its topical/transdermal cannabis products for Nevada
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
OVATION SCIENCE INC

OTC:OVATF

OVATF Rankings

OVATF Stock Data

1.21M
21.99M
26.97%
Testing Laboratories
Professional, Scientific, and Technical Services
Link
United States of America
Vancouver